Carvykti Avrupa Birliği - Romence - EMA (European Medicines Agency)

carvykti

janssen-cilag international nv - ciltacabtagene autoleucel - mielom multiplu - carvykti is indicated for the treatment of adult patients with relapsed and refractory multiple myeloma, who have received at least three prior therapies, including an immunomodulatory agent, a proteasome inhibitor and an anti-cd38 antibody and have demonstrated disease progression on the last therapy.

Cidelon picaturi oftalmice, solutie 2,5 mg + 0,2 mg/ml Moldova - Romence - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

cidelon picaturi oftalmice, solutie 2,5 mg + 0,2 mg/ml

gntls srl, uzina experimentala - zinci sulfas + decametoxinum - picaturi oftalmice, solutie - 2,5 mg + 0,2 mg/ml

Cloromicol unguent 7,5 mg + 40 mg/g Moldova - Romence - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

cloromicol unguent 7,5 mg + 40 mg/g

farmaprim srl - chloramphenicolum + methyluracilum - unguent - 7,5 mg + 40 mg/g

Cloromicol unguent 7,5 mg + 40 mg/g Moldova - Romence - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

cloromicol unguent 7,5 mg + 40 mg/g

farmaprim srl - chloramphenicolum + methyluracilum - unguent - 7,5 mg + 40 mg/g